Cite Filings / TPST / 0001931356-26-000009

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Tempest Therapeutics, Inc. Filed 2026-02-10 Acc 0001931356-26-000009

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2026-02-11 8-K Regulation FD disclosure
2026-02-10 SCHEDULE 13D Beneficial Ownership Report
2026-02-06 4 Options or other derivatives
2026-02-06 3 Initial Statement of Ownership
2026-02-06 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Change in control · Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…